Lina Geng

Dr. Lina Geng


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2024 in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
Verified
Journal Article
Closed access
DZDongwei Zhu
Dongwei Zhu
JDJindong Dai
Jindong Dai
JJJue Jia
Jue Jia
TKThangamani Kanagaraj
Thangamani Kanagaraj
KRKanagaraj Rajalakshmi
Kanagaraj Rajalakshmi
GYGuoyue Yuan
Guoyue Yuan

19 April 2024 in Medicine
Verified
Journal Article
Open access
LGLina Geng
Lina Geng
QCQiang Cuixin
Qiang Cuixin
ZXZhang Xia
Zhang Xia
YJYang Jing
Yang Jing
LZLi Zhirong
Li Zhirong
JZJianhong Zhao
Jianhong Zhao
An increase in CD4+ T cells in the synovium is closely linked to the pathogenesis of rheumatoid arthritis (RA). We aimed to identify the possible causes of the elevated CD4+ T cell levels and to explore the factors influencing disease activity in RA. Fifty-five RA patients, including 28 with active RA (ARA), 27 with inactive RA, and 22 healthy controls, were recruited for this study. The proportion of CCR9+CD4+ T cells and the expression of chemokine receptor 9 (CCR9) on CD4+ T cells were analyzed by flow cytometry. Enzyme-linked immunosorbent assay and chemiluminescent immunoassay were used to evaluate interleukin (IL)-17A and IL-6 levels, respectively. The proportion of CCR9+CD4+ T cells and the expression of CCR9 on CD4+ T cells increased significantly in peripheral blood (PB) and synovial fluid (SF) in ARA compared to those in inactive RA. Furthermore, SF contained more CCR9+CD4+ T cells, IL-6, and IL-17A than PB in RA patients. Moreover, CD4+ T cells in the PB of patients with RA, especially ARA, expressed more CCR9 and secreted more IL-6 and IL-17A after activation. Here, we also demonstrated that both the percentage of CCR9+ cells in CD4+ T cells and the expression of CCR9 on circulating CD4+ T cells were positively correlated with erythrocyte sedimentation rate, hypersensitive C-reactive protein, rheumatoid factor, and anti-cyclic citrullinated peptide antibody. CCR9+CD4+ T cells are elevated in PB and SF, and are associated with disease activity in patients with RA.

27 March 2025 in Clinical Rheumatology
Verified
Journal Article
Closed access
PDF file
LGLina Geng
Lina Geng
TLTing Li
Ting Li
YLYan Liu
Yan Liu
XLXuntao Liu
Xuntao Liu
JWJing Wang
Jing Wang
BZBin Zhang
Bin Zhang

19 April 2021 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
LGLina Geng
Lina Geng
JYJun Yang
Jun Yang
XTXinyi Tang
Xinyi Tang
HPHuiyong Peng
Huiyong Peng
JTJie Tian
Jie Tian
Shengjun WangShengjun Wang
Shengjun Wang
Signaling lymphocytic activation molecule (SLAM) and SLAM-associated protein (SAP) play important role in inflammatory and autoimmune diseases. Our study is aimed at detecting the expression of SLAM and SAP in patients with Graves disease (GD) and analyzing the effect of SLAM/SAP on circulating blood CD4+CXCR5+Foxp3+ follicular regulatory T (Tfr) cells. The level of SAP in CD4+CXCR5+ T cells and the level of SLAM on CD19+ B cells were significantly increased in the patients with GD, but no significant difference in the level of SLAM on CD4+CXCR5+ T cells was observed between the patients with GD and the healthy controls. A decrease in the percentage of Foxp3+ cells in CD4+CXCR5+ T cells was observed following anti-SLAM treatment, but the percentages of IFN-γ+ cells, IL-4+ cells, and IL-17+ cells showed no obvious differences. The proportion of circulating Tfr cells was decreased in the patients with GD, and the proportion of circulating Tfr cells had a negative correlation with the level of SAP in CD4+CXCR5+ T cells and the levels of autoantibodies in the serum of the patients with GD. Our results suggested that the SLAM/SAP signaling pathway is involved in the decrease of circulating Tfr cells in Graves disease.